Oruka Therapeutics, Inc. Research and Development Expense
Oruka Therapeutics, Inc. (ORKA) reported Research and Development Expense of $43.26 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-10
- Oruka Therapeutics, Inc. research and development expense for the quarter ending 2026-06-30 was $43.26M, a 79.59% increase year-over-year.
- Oruka Therapeutics, Inc. research and development expense for the quarter ending 2026-03-31 was $29.14M, a 46.27% increase year-over-year.
- Oruka Therapeutics, Inc. research and development expense for the quarter ending 2025-12-31 was $27.64M.
- Oruka Therapeutics, Inc. research and development expense for the quarter ending 2025-09-30 was $28.99M, a 12.83% increase year-over-year.
- Oruka Therapeutics, Inc. research and development expense for fiscal 2025 was $100.64M.
- Oruka Therapeutics, Inc. research and development expense for fiscal 2023 was $1.01M, a 78.67% decline from fiscal 2022.
- Oruka Therapeutics, Inc. research and development expense for fiscal 2022 was $4.75M, a 65.67% decline from fiscal 2021.
- Oruka Therapeutics, Inc. research and development expense for fiscal 2021 was $13.83M, a 177.08% increase from fiscal 2020.
| Period end | Research and Development Expense 2 month | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 5 month | Research and Development Expense 6 month | Research and Development Expense 8 month | Research and Development Expense 9 month | Research and Development Expense 11 month | Research and Development Expense 12 month | Research and Development Expense 114 month | Research and Development Expense 117 month | Research and Development Expense 120 month | Research and Development Expense 123 month | Research and Development Expense 126 month | Research and Development Expense 129 month | Research and Development Expense 132 month | Research and Development Expense 135 month | Research and Development Expense 138 month | Research and Development Expense 141 month | Research and Development Expense 144 month | Research and Development Expense 147 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $43.26M 10-Q · filed 2026-08-10 | $72.40M 10-Q · filed 2026-08-10 | $100.04M derived: sum of 3 quarters · filed 2026-08-10 | $129.03M derived: sum of 4 quarters · filed 2026-08-10 | |||||||||||||||||
| 2026-03-31 | $29.14M 10-Q · filed 2026-05-13 | $56.78M derived: sum of 2 quarters · filed 2026-05-13 | $85.77M derived: sum of 3 quarters · filed 2026-05-13 | $109.86M derived: sum of 4 quarters · filed 2026-08-10 | |||||||||||||||||
| 2025-12-31 | $27.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $56.63M derived: sum of 2 quarters · filed 2026-03-12 | $80.72M derived: sum of 3 quarters · filed 2026-08-10 | $100.64M 10-K · filed 2026-03-12 | |||||||||||||||||
| 2025-09-30 | $28.99M 10-Q · filed 2025-11-12 | $53.08M derived: sum of 2 quarters · filed 2026-08-10 | $73.00M 10-Q · filed 2025-11-12 | ||||||||||||||||||
| 2025-06-30 | $24.09M 10-Q · filed 2026-08-10 | $44.01M 10-Q · filed 2026-08-10 | |||||||||||||||||||
| 2025-03-31 | $19.93M 10-Q · filed 2026-05-13 | ||||||||||||||||||||
| 2024-12-31 | $75.06M 10-K · filed 2026-03-12 | ||||||||||||||||||||
| 2024-09-30 | $25.69M 10-Q · filed 2025-11-12 | $44.36M derived: sum of 2 quarters · filed 2025-11-12 | $49.56M 10-Q · filed 2025-11-12 | $44.53M derived: sum of 3 quarters · filed 2025-11-12 | $44.58M derived: sum of 4 quarters · filed 2025-11-12 | ||||||||||||||||
| 2024-06-30 | $18.67M 10-Q · filed 2025-08-11 | $130.00K 10-Q · filed 2024-08-01 | $23.87M 10-Q · filed 2025-08-11 | $295.00K 10-Q · filed 2024-08-01 | $18.89M derived: sum of 3 quarters · filed 2025-08-11 | $19.21M derived: sum of 4 quarters · filed 2025-08-11 | |||||||||||||||
| 2024-03-31 | $5.19M 10-Q · filed 2025-05-14 | $165.00K 10-Q · filed 2024-04-25 | $212.00K derived: sum of 2 quarters · filed 2024-04-25 | $534.00K derived: sum of 3 quarters · filed 2024-04-25 | $788.00K derived: sum of 4 quarters · filed 2024-08-01 | ||||||||||||||||
| 2023-12-31 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-01 | $369.00K derived: sum of 2 quarters · filed 2024-02-01 | $623.00K derived: sum of 3 quarters · filed 2024-08-01 | $1.01M 10-K · filed 2024-02-01 | |||||||||||||||||
| 2023-09-30 | $322.00K 10-Q · filed 2023-10-18 | $576.00K derived: sum of 2 quarters · filed 2024-08-01 | $966.00K 10-Q · filed 2023-10-18 | $1.03M derived: sum of 4 quarters · filed 2024-08-01 | |||||||||||||||||
| 2023-06-30 | $254.00K 10-Q · filed 2024-08-01 | $644.00K 10-Q · filed 2024-08-01 | $705.00K derived: sum of 3 quarters · filed 2024-08-01 | $1.73M derived: sum of 4 quarters · filed 2024-08-01 | |||||||||||||||||
| 2023-03-31 | $390.00K 10-Q · filed 2024-04-25 | $451.00K derived: sum of 2 quarters · filed 2024-04-25 | $1.48M derived: sum of 3 quarters · filed 2024-04-25 | $2.96M derived: sum of 4 quarters · filed 2024-04-25 | |||||||||||||||||
| 2022-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-01 | $1.08M derived: sum of 2 quarters · filed 2024-02-01 | $2.57M derived: sum of 3 quarters · filed 2024-02-01 | $4.75M 10-K · filed 2024-02-01 | |||||||||||||||||
| 2022-09-30 | $1.02M 10-Q · filed 2023-10-18 | $2.51M derived: sum of 2 quarters · filed 2023-10-18 | $4.69M 10-Q · filed 2023-10-18 | $8.63M derived: sum of 4 quarters · filed 2023-10-18 | |||||||||||||||||
| 2022-06-30 | $1.49M 10-Q · filed 2023-07-21 | $3.66M 10-Q · filed 2023-07-21 | $7.61M derived: sum of 3 quarters · filed 2023-07-21 | $11.04M derived: sum of 4 quarters · filed 2023-07-21 | |||||||||||||||||
| 2022-03-31 | $2.18M 10-Q · filed 2023-04-24 | $6.12M derived: sum of 2 quarters · filed 2023-04-24 | $9.56M derived: sum of 3 quarters · filed 2023-04-24 | $13.13M derived: sum of 4 quarters · filed 2023-04-24 | |||||||||||||||||
| 2021-12-31 | $3.94M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $7.38M derived: sum of 2 quarters · filed 2023-02-24 | $10.96M derived: sum of 3 quarters · filed 2023-02-24 | $13.83M 10-K · filed 2023-02-24 | |||||||||||||||||
| 2021-09-30 | $3.44M 10-Q · filed 2022-10-28 | $7.01M derived: sum of 2 quarters · filed 2022-10-28 | $9.89M 10-Q · filed 2022-10-28 | $13.10M derived: sum of 4 quarters · filed 2022-10-28 | |||||||||||||||||
| 2021-06-30 | $3.58M 10-Q · filed 2022-08-02 | $6.45M 10-Q · filed 2022-08-02 | $9.66M derived: sum of 3 quarters · filed 2022-08-02 | $10.71M derived: sum of 4 quarters · filed 2022-08-02 | |||||||||||||||||
| 2021-03-31 | $2.88M 10-Q · filed 2022-05-02 | $6.08M derived: sum of 2 quarters · filed 2022-05-02 | $7.13M derived: sum of 3 quarters · filed 2022-05-02 | $7.50M derived: sum of 4 quarters · filed 2022-05-02 | |||||||||||||||||
| 2020-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $4.25M derived: sum of 2 quarters · filed 2022-03-14 | $4.63M derived: sum of 3 quarters · filed 2022-03-14 | $4.99M 10-K · filed 2022-03-14 | |||||||||||||||||
| 2020-09-30 | $1.05M 10-Q · filed 2021-11-02 | $1.42M derived: sum of 2 quarters · filed 2021-11-02 | $1.79M 10-Q · filed 2021-11-02 | $2.17M derived: sum of 4 quarters · filed 2021-11-02 | |||||||||||||||||
| 2020-06-30 | $372.00K 10-Q · filed 2021-08-04 | $737.00K 10-Q · filed 2021-08-04 | $1.12M derived: sum of 3 quarters · filed 2021-08-04 | $1.47M derived: sum of 4 quarters · filed 2021-08-04 | |||||||||||||||||
| 2020-03-31 | $365.00K 10-Q · filed 2021-05-11 | $749.00K derived: sum of 2 quarters · filed 2021-05-11 | $1.10M derived: sum of 3 quarters · filed 2021-05-11 | $1.54M derived: sum of 4 quarters · filed 2021-05-11 | |||||||||||||||||
| 2019-12-31 | $384.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $731.00K derived: sum of 2 quarters · filed 2021-03-18 | $1.17M derived: sum of 3 quarters · filed 2021-03-18 | $1.83M 10-K · filed 2021-03-18 | |||||||||||||||||
| 2019-09-30 | $347.00K 10-Q · filed 2020-11-02 | $787.00K derived: sum of 2 quarters · filed 2020-11-02 | $1.45M 10-Q · filed 2020-11-02 | $2.07M derived: sum of 4 quarters · filed 2020-11-02 | |||||||||||||||||
| 2019-06-30 | $440.00K 10-Q · filed 2020-08-05 | $1.10M 10-Q · filed 2020-08-05 | $1.73M derived: sum of 3 quarters · filed 2020-08-05 | $2.47M derived: sum of 4 quarters · filed 2020-08-05 | |||||||||||||||||
| 2019-03-31 | $662.00K 10-Q · filed 2020-05-06 | $1.29M derived: sum of 2 quarters · filed 2020-05-06 | $2.03M derived: sum of 3 quarters · filed 2020-05-06 | $3.18M derived: sum of 4 quarters · filed 2020-05-06 | |||||||||||||||||
| 2018-12-31 | $625.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $1.36M derived: sum of 2 quarters · filed 2020-02-18 | $2.52M derived: sum of 3 quarters · filed 2020-02-18 | $4.24M 10-K · filed 2020-02-18 | |||||||||||||||||
| 2018-09-30 | $740.00K 10-Q · filed 2019-11-06 | $1.89M derived: sum of 2 quarters · filed 2019-11-06 | $3.61M 10-Q · filed 2019-11-06 | $6.45M derived: sum of 4 quarters · filed 2019-11-06 | |||||||||||||||||
| 2018-06-30 | $1.15M 10-Q · filed 2019-08-01 | $2.87M 10-Q · filed 2019-08-01 | $5.71M derived: sum of 3 quarters · filed 2019-08-01 | $9.20M derived: sum of 4 quarters · filed 2019-08-01 | |||||||||||||||||
| 2018-03-31 | $1.72M 10-Q · filed 2019-05-08 | $4.55M derived: sum of 2 quarters · filed 2019-05-08 | $8.04M derived: sum of 3 quarters · filed 2019-05-08 | $12.55M derived: sum of 4 quarters · filed 2019-05-08 | |||||||||||||||||
| 2017-12-31 | $2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $6.32M derived: sum of 2 quarters · filed 2019-02-27 | $10.83M derived: sum of 3 quarters · filed 2019-02-27 | $14.08M 10-K · filed 2019-02-27 | |||||||||||||||||
| 2017-09-30 | $3.49M 10-Q · filed 2018-11-14 | $8.00M derived: sum of 2 quarters · filed 2018-11-14 | $11.24M 10-Q · filed 2018-11-14 | $14.36M derived: sum of 4 quarters · filed 2018-11-14 | |||||||||||||||||
| 2017-06-30 | $4.51M 10-Q · filed 2018-08-09 | $7.75M 10-Q · filed 2018-08-09 | $10.88M derived: sum of 3 quarters · filed 2018-08-09 | $14.60M derived: sum of 4 quarters · filed 2018-08-09 | |||||||||||||||||
| 2017-03-31 | $3.25M 10-Q · filed 2018-05-08 | $6.37M derived: sum of 2 quarters · filed 2018-05-08 | $10.09M derived: sum of 3 quarters · filed 2018-05-08 | $13.00M derived: sum of 4 quarters · filed 2018-05-08 | |||||||||||||||||
| 2016-12-31 | $3.12M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $6.84M derived: sum of 2 quarters · filed 2018-03-22 | $9.75M derived: sum of 3 quarters · filed 2018-03-22 | $12.35M 10-K · filed 2018-03-22 | |||||||||||||||||
| 2016-09-30 | $3.72M 10-Q · filed 2017-11-09 | $6.63M derived: sum of 2 quarters · filed 2017-11-09 | $9.23M 10-Q · filed 2017-11-09 | $11.12M derived: sum of 4 quarters · filed 2017-11-09 | |||||||||||||||||
| 2016-06-30 | $2.91M 10-Q · filed 2017-08-03 | $5.51M 10-Q · filed 2017-08-03 | $7.40M derived: sum of 3 quarters · filed 2017-08-03 | $9.12M derived: sum of 4 quarters · filed 2017-08-03 | |||||||||||||||||
| 2016-03-31 | $2.59M 10-Q · filed 2017-05-15 | $4.49M derived: sum of 2 quarters · filed 2017-05-15 | $6.20M derived: sum of 3 quarters · filed 2017-05-15 | $7.95M derived: sum of 4 quarters · filed 2017-05-15 | |||||||||||||||||
| 2015-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-21 | $3.61M derived: sum of 2 quarters · filed 2017-03-21 | $5.36M derived: sum of 3 quarters · filed 2017-03-21 | $7.06M 10-K · filed 2017-03-21 | |||||||||||||||||
| 2015-09-30 | $1.72M 10-Q · filed 2016-11-14 | $3.46M derived: sum of 2 quarters · filed 2016-11-14 | $5.17M 10-Q · filed 2016-11-14 | $6.75M derived: sum of 4 quarters · filed 2016-11-14 | |||||||||||||||||
| 2015-06-30 | $1.75M 10-Q · filed 2016-08-09 | $3.45M 10-Q · filed 2016-08-09 | $5.04M derived: sum of 3 quarters · filed 2016-08-09 | $6.37M derived: sum of 4 quarters · filed 2016-08-09 | |||||||||||||||||
| 2015-03-31 | $1.71M 10-Q · filed 2016-05-11 | $3.29M derived: sum of 2 quarters · filed 2016-05-11 | $4.62M derived: sum of 3 quarters · filed 2016-05-11 | $6.02M derived: sum of 4 quarters · filed 2016-05-11 | |||||||||||||||||
| 2014-12-31 | $1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-17 | $2.92M derived: sum of 2 quarters · filed 2016-03-17 | $4.32M derived: sum of 3 quarters · filed 2016-03-17 | $5.63M 10-K · filed 2016-03-17 | |||||||||||||||||
| 2014-09-30 | $1.33M 10-Q · filed 2015-11-12 | $2.73M derived: sum of 2 quarters · filed 2015-11-12 | $4.04M 10-Q · filed 2015-11-12 | $5.83M derived: sum of 4 quarters · filed 2015-11-12 | |||||||||||||||||
| 2014-06-30 | $1.40M 10-Q · filed 2015-08-11 | $2.71M 10-Q · filed 2015-08-11 | $4.50M derived: sum of 3 quarters · filed 2015-08-11 | $5.21M derived: sum of 4 quarters · filed 2015-08-11 | |||||||||||||||||
| 2014-03-31 | $1.31M 10-Q · filed 2015-05-12 | $3.10M derived: sum of 2 quarters · filed 2015-05-12 | $3.81M derived: sum of 3 quarters · filed 2015-05-12 | $4.05M derived: sum of 4 quarters · filed 2015-05-12 | $46.91M 10-Q · filed 2014-05-13 | ||||||||||||||||
| 2013-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19 | $2.50M derived: sum of 2 quarters · filed 2015-03-19 | $2.75M derived: sum of 3 quarters · filed 2015-03-19 | $2.93M 10-K · filed 2015-03-19 | $45.60M 10-K · filed 2014-03-20 | ||||||||||||||||
| 2013-09-30 | $714.00K 10-Q · filed 2014-11-12 | $960.00K derived: sum of 2 quarters · filed 2014-11-12 | $1.14M 10-Q · filed 2014-11-12 | $1.33M derived: sum of 4 quarters · filed 2014-11-12 | $43.82M 10-Q · filed 2013-11-13 | ||||||||||||||||
| 2013-06-30 | $246.00K 10-Q · filed 2014-08-13 | $427.00K 10-Q · filed 2014-08-13 | $618.00K derived: sum of 3 quarters · filed 2014-08-13 | $774.00K derived: sum of 4 quarters · filed 2014-08-13 | $43.10M 10-Q · filed 2013-08-13 | ||||||||||||||||
| 2013-03-31 | $181.00K 10-Q · filed 2014-05-13 | $372.00K derived: sum of 2 quarters · filed 2014-05-13 | $528.00K derived: sum of 3 quarters · filed 2014-05-13 | $850.00K derived: sum of 4 quarters · filed 2014-05-13 | $42.86M 10-Q · filed 2013-05-13 | ||||||||||||||||
| 2012-12-31 | $191.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | $347.00K derived: sum of 2 quarters · filed 2014-03-20 | $669.00K derived: sum of 3 quarters · filed 2014-03-20 | $1.09M 10-K · filed 2014-03-20 | $42.68M 10-K · filed 2013-03-21 | ||||||||||||||||
| 2012-09-30 | $156.00K 10-Q · filed 2013-11-13 | $478.00K derived: sum of 2 quarters · filed 2013-11-13 | $901.00K 10-Q · filed 2013-11-13 | $1.50M derived: sum of 4 quarters · filed 2013-11-13 | $42.49M 10-Q · filed 2012-11-13 | ||||||||||||||||
| 2012-06-30 | $322.00K 10-Q · filed 2013-08-13 | $744.00K 10-Q · filed 2013-08-13 | $1.34M derived: sum of 3 quarters · filed 2013-08-13 | $1.87M derived: sum of 4 quarters · filed 2013-08-13 | $42.33M 10-Q · filed 2012-08-13 | ||||||||||||||||
| 2012-03-31 | $422.00K 10-Q · filed 2013-05-13 | $1.02M derived: sum of 2 quarters · filed 2013-05-13 | $1.55M derived: sum of 3 quarters · filed 2013-05-13 | $2.05M derived: sum of 4 quarters · filed 2013-05-13 | $42.01M 10-Q · filed 2012-05-14 | ||||||||||||||||
| 2011-12-31 | $595.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-21 | $1.13M derived: sum of 2 quarters · filed 2013-03-21 | $1.63M derived: sum of 3 quarters · filed 2013-03-21 | $2.31M 10-K · filed 2013-03-21 | $41.59M 10-K · filed 2012-03-27 | ||||||||||||||||
| 2011-09-30 | $533.00K 10-Q · filed 2012-11-13 | $1.03M derived: sum of 2 quarters · filed 2012-11-13 | $1.72M 10-Q · filed 2012-11-13 | $2.58M derived: sum of 4 quarters · filed 2012-11-13 | $40.99M 10-Q · filed 2011-11-14 | ||||||||||||||||
| 2011-06-30 | $497.00K 10-Q · filed 2012-08-13 | $1.19M 10-Q · filed 2012-08-13 | $2.05M derived: sum of 3 quarters · filed 2012-08-13 | $2.77M derived: sum of 4 quarters · filed 2012-08-13 | $40.46M 10-Q · filed 2011-08-15 | ||||||||||||||||
| 2011-03-31 | $690.00K 10-Q · filed 2012-05-14 | $1.55M derived: sum of 2 quarters · filed 2012-05-14 | $2.28M derived: sum of 3 quarters · filed 2012-05-14 | $2.98M derived: sum of 4 quarters · filed 2012-05-14 | |||||||||||||||||
| 2010-12-31 | $860.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-27 | $1.59M derived: sum of 2 quarters · filed 2012-03-27 | $2.29M derived: sum of 3 quarters · filed 2012-03-27 | $3.11M 10-K · filed 2012-03-27 | |||||||||||||||||
| 2010-09-30 | $726.00K 10-Q · filed 2011-11-14 | $1.43M derived: sum of 2 quarters · filed 2011-11-14 | $2.25M 10-Q · filed 2011-11-14 | ||||||||||||||||||
| 2010-06-30 | $700.00K 10-Q · filed 2011-08-15 | $1.52M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |